9GBS | pdb_00009gbs

Human Angiotensin-1 converting enzyme N-domain in complex with a diprolyl inhibitor- SG18

X-RAY DIFFRACTION

Starting Model(s)

Initial Refinement Model(s)
Type	Source	Accession Code	Details
experimental model	PDB	6F9V

Crystallization

Crystalization Experiments
ID	Method	pH	Temperature	Details
1	VAPOR DIFFUSION, HANGING DROP		289.15	1 M Tris/Bicine pH8.5 60 mM divalent cations (MgCl2 and CaCl2) 30% PEG550 MME/PEG20K

Crystal Properties
Matthews coefficient	Solvent content
2.86	57.05

Crystal Data

Unit Cell
Length ( Å )	Angle ( ˚ )
a = 72.723	α = 88.371
b = 77.164	β = 64.577
c = 81.841	γ = 75.247

Symmetry
Space Group	P 1

Diffraction

Diffraction Experiment
ID #	Crystal ID	Scattering Type	Data Collection Temperature	Detector	Detector Type	Details	Collection Date	Monochromator	Protocol
1	1	x-ray	100	PIXEL	DECTRIS EIGER2 XE 16M		2019-08-04	M	SINGLE WAVELENGTH

Radiation Source
ID #	Source	Type	Wavelength List	Synchrotron Site	Beamline
1	SYNCHROTRON	DIAMOND BEAMLINE I03	0.9763	Diamond	I03

Data Collection

Overall
ID #	Resolution (High)	Resolution (Low)	Percent Possible (Observed)	Rpim I (All)	CC (Half)	Net I Over Average Sigma (I)	Redundancy	Number Reflections (All)	Number Reflections (Observed)	Observed Criterion Sigma (F)	Observed Criterion Sigma (I)	B (Isotropic) From Wilson Plot
1	1.9	73.6	97.8	0.063	0.996	7.5	7.1		119232

Highest Resolution Shell
ID #	Resolution (High)	Resolution (Low)	Percent Possible (All)	Percent Possible (Observed)	Rpim I (All)	CC (Half)	Mean I Over Sigma (Observed)	Redundancy	Number Unique Reflections (All)
1	1.9	1.93			1.629	0.433

Refinement

Statistics
Diffraction ID	Structure Solution Method	Cross Validation method	Resolution (High)	Resolution (Low)	Number Reflections (Observed)	Number Reflections (R-Free)	Percent Reflections (Observed)	R-Factor (All)	R-Work (Depositor)	R-Work (DCC)	R-Free (Depositor)	R-Free (DCC)	Mean Isotropic B
X-RAY DIFFRACTION	MOLECULAR REPLACEMENT	FREE R-VALUE	1.9	63.722	119217	5877	97.757	0.167	0.165	0.1658	0.2041	0.2056	36.005

Temperature Factor Modeling
Anisotropic B[1][1]	Anisotropic B[1][2]	Anisotropic B[1][3]	Anisotropic B[2][2]	Anisotropic B[2][3]	Anisotropic B[3][3]
-0.098	1.169	1.014	0.863	1.258	0.11

RMS Deviations
Key	Refinement Restraint Deviation
r_dihedral_angle_6_deg	15.435
r_dihedral_angle_3_deg	14.482
r_lrange_it	9.977
r_scangle_it	9.064
r_dihedral_angle_2_deg	8.764
r_scbond_it	6.604
r_dihedral_angle_1_deg	6.567
r_mcangle_it	5.113
r_mcbond_it	4.083
r_angle_refined_deg	2.4

RMS Deviations
Key	Refinement Restraint Deviation
r_dihedral_angle_6_deg	15.435
r_dihedral_angle_3_deg	14.482
r_lrange_it	9.977
r_scangle_it	9.064
r_dihedral_angle_2_deg	8.764
r_scbond_it	6.604
r_dihedral_angle_1_deg	6.567
r_mcangle_it	5.113
r_mcbond_it	4.083
r_angle_refined_deg	2.4
r_nbtor_refined	0.323
r_nbd_refined	0.237
r_symmetry_nbd_refined	0.2
r_chiral_restr	0.155
r_xyhbond_nbd_refined	0.154
r_symmetry_xyhbond_nbd_refined	0.153
r_bond_refined_d	0.015
r_gen_planes_refined	0.014

Non-Hydrogen Atoms Used in Refinement
Non-Hydrogen Atoms	Number
Protein Atoms	9860
Nucleic Acid Atoms
Solvent Atoms	659
Heterogen Atoms	389

Software

Software
Software Name	Purpose
REFMAC	refinement
DIALS	data reduction
Aimless	data scaling
PHASER	phasing

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.